Search results
Showing 106 to 120 of 1515 results for patients and public
Seladelpar for previously treated primary biliary cholangitis [ID6429]
In development Reference number: GID-TA11540 Expected publication date: TBC
Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]
In development Reference number: GID-TA11572 Expected publication date: 21 May 2026
expenditure. You'll find this in the finance and workforce report section in our public board papers. Annual report (PDF) . This...
This guideline covers rehabilitation strategies for adults who have experienced a critical illness and stayed in critical care. It aims to improve physical, psychological and cognitive outcomes in people who have been discharged from critical care.
Involving you in the development of NICE guidance.
Involving you in the development of NICE guidance.
Pembrolizumab with chemoradiation for untreated high-risk locally advanced cervical cancer [ID6138]
Awaiting development Reference number: GID-TA11215 Expected publication date: 07 May 2026
In development Reference number: GID-TA10990 Expected publication date: TBC
In development Reference number: GID-TA10143 Expected publication date: TBC
Lenacapavir for preventing HIV-1 in people aged 16 years or older [ID6495]
In development Reference number: GID-TA11638 Expected publication date: TBC
In development Reference number: GID-TA11488 Expected publication date: 15 July 2026
In development Reference number: GID-TA11498 Expected publication date: 29 April 2026
An outline of the roles and responsibilities of the National Institute for Health and Care Excellence.
How voluntary and community sector organisations can help us develop guidance
How voluntary and community sector (VCS) organisations can help NICE develop guidance
How voluntary and community sector organisations can help us develop guidance
How voluntary and community sector (VCS) organisations can help NICE develop guidance